To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer
Clinical trial NCT06808412 · RECRUITING
Trial details
- NCT number
- NCT06808412
- Sponsor
- xiaohua li
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-05
- Primary completion
- 2025-05-05
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.